S-1 and Oxaliplatin (SOX) Plus Sintilimab in the Locally Advanced Esophagogastric Junction Adenocarcinoma

NCT04989985 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

302

Enrollment

OTHER

Sponsor class

Conditions

Locally Advanced Gastroesophageal Junction Adenocarcinoma
Chemotherapy Effect

Interventions

DRUG: Oxaliplatin+S-1
DRUG: Sinitilimab+oxaliplatin+S-1

Sponsor

Sixth Affiliated Hospital, Sun Yat-sen University

Collaborators

[object Object]